Rita J Desai

Array ( [id] => 307588 [patent_doc_number] => 07531654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Process for producing substituted aniline compound' [patent_app_type] => utility [patent_app_number] => 11/790939 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13854 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531654.pdf [firstpage_image] =>[orig_patent_app_number] => 11790939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6604834 [patent_doc_number] => 20100063078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'SPIROCOMPOUNDS USEFUL AS MODULATORS FOR DOPAMINE D3 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/297253 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21053 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063078.pdf [firstpage_image] =>[orig_patent_app_number] => 12297253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960638 [patent_doc_number] => 20080275063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Inhibitors of protein kinases' [patent_app_type] => utility [patent_app_number] => 11/789291 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20767 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275063.pdf [firstpage_image] =>[orig_patent_app_number] => 11789291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7597614 [patent_doc_number] => 07618963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Bicyclic heteroaromatic compounds' [patent_app_type] => utility [patent_app_number] => 11/788886 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18664 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618963.pdf [firstpage_image] =>[orig_patent_app_number] => 11788886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322656 [patent_doc_number] => 07517889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => '2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/735760 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86296 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517889.pdf [firstpage_image] =>[orig_patent_app_number] => 11735760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341672 [patent_doc_number] => 07501430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'RAF inhibitors and their uses' [patent_app_type] => utility [patent_app_number] => 11/785163 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 46787 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501430.pdf [firstpage_image] =>[orig_patent_app_number] => 11785163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231383 [patent_doc_number] => 20070293491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'INDAZOLE COMPOUNDS AND METHODS FOR INHIBITION OF CDC7' [patent_app_type] => utility [patent_app_number] => 11/735302 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18545 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293491.pdf [firstpage_image] =>[orig_patent_app_number] => 11735302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5178058 [patent_doc_number] => 20070179118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => '2-(PYRIDIN-2-YLAMINO)-PYRIDO [2,3 D]PYRIMIDIN-7-ONES' [patent_app_type] => utility [patent_app_number] => 11/734200 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45461 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179118.pdf [firstpage_image] =>[orig_patent_app_number] => 11734200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070282 [patent_doc_number] => 20070191384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Use of Substituted 8-Perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] Pyrimidin-4-one Derivatives as Therapeutic Agents' [patent_app_type] => utility [patent_app_number] => 11/696256 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7858 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191384.pdf [firstpage_image] =>[orig_patent_app_number] => 11696256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334325 [patent_doc_number] => 07507737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4receptor' [patent_app_type] => utility [patent_app_number] => 11/731074 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16078 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507737.pdf [firstpage_image] =>[orig_patent_app_number] => 11731074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211058 [patent_doc_number] => 20070249642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione' [patent_app_type] => utility [patent_app_number] => 11/693756 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60403 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249642.pdf [firstpage_image] =>[orig_patent_app_number] => 11693756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294479 [patent_doc_number] => 08222266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Azabicyclo [3.1.0] hexyl derivatives as modulators of dopamine D3 receptors' [patent_app_type] => utility [patent_app_number] => 12/295304 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22528 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12295304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146740 [patent_doc_number] => 08163745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines' [patent_app_type] => utility [patent_app_number] => 12/294725 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13448 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163745.pdf [firstpage_image] =>[orig_patent_app_number] => 12294725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720339 [patent_doc_number] => 20080242862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Novel imidazo based heterocycles' [patent_app_type] => utility [patent_app_number] => 11/728919 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19773 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242862.pdf [firstpage_image] =>[orig_patent_app_number] => 11728919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257249 [patent_doc_number] => 20100029626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Cyclic sulfones useful as mitochondrial sodium-calcium exchangers' [patent_app_type] => utility [patent_app_number] => 12/446955 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28189 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029626.pdf [firstpage_image] =>[orig_patent_app_number] => 12446955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522028 [patent_doc_number] => 20090030009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Heterobicyclic Carboxamides as Inhibitors for Kinases' [patent_app_type] => utility [patent_app_number] => 12/281715 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28755 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030009.pdf [firstpage_image] =>[orig_patent_app_number] => 12281715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515148 [patent_doc_number] => 07910598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase' [patent_app_type] => utility [patent_app_number] => 11/714565 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 6 [patent_no_of_words] => 15480 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910598.pdf [firstpage_image] =>[orig_patent_app_number] => 11714565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417023 [patent_doc_number] => 20090042910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'QUINOLINE DERIVATIVES FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/280854 [patent_app_country] => US [patent_app_date] => 2007-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44291 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042910.pdf [firstpage_image] =>[orig_patent_app_number] => 12280854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005589 [patent_doc_number] => 20070203161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY' [patent_app_type] => utility [patent_app_number] => 11/678429 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89038 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203161.pdf [firstpage_image] =>[orig_patent_app_number] => 11678429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005590 [patent_doc_number] => 20070203162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY' [patent_app_type] => utility [patent_app_number] => 11/678488 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66719 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203162.pdf [firstpage_image] =>[orig_patent_app_number] => 11678488 [rel_patent_id] =>[rel_patent_doc_number] =>)